T Laskus|M Radkowski|L F Wang|H Vargas|J Rakela - JoVE Visualize

Showing results (71-80 of 776) with videos related to

Pageof 78

Sort By:

Polskie Archiwum Medycyny Wewnetrznej|January 1, 1992

[Occurrence of antibodies against hepatitis C virus (HCV) among drug addicts]T Laskus, M Radkowski, T Werezyńska, et al.

Polskie Archiwum Medycyny Wewnetrznej|February 1, 1992

[Markers of HBV infection in drug addicts]T Laskus, M Radkowski, T Werezyńska, et al.

Polskie Archiwum Medycyny Wewnetrznej|November 1, 1991

[Delta virus infection among drug addicts]T Laskus, M Radkowski, E Lupa, et al.

Journal of Hepatology|May 1, 1992

Prevalence of markers of hepatotropic viruses among drug addicts in Warsaw, PolandT Laskus, M Radkowski, E Lupa, et al.

Polskie Archiwum Medycyny Wewnetrznej|December 1, 1991

[Influence of therapy with glucocorticosteroids on clinical status, t4 lymphocyte count and t4/t8 lymphocyte ratio in people infected with AIDS]M Radkowski, T Laskus, E Kopicz-Kamińska, et al.

Polski Tygodnik Lekarski (Warsaw, Poland : 1960)|March 1, 1993

[Appearance of thrombocytopenia in patients infected with HIV]M Radkowski, T Laskus, B Szymańska, et al.

Journal of Hepatology|June 1, 1994

Naturally occurring hepatitis B virus mutants with deletions in the core promoter regionT Laskus, J Rakela, M J Tong, et al.

Polskie Archiwum Medycyny Wewnetrznej|August 1, 1993

[Evaluation of humoral immune response in patients with asymptomatic and symptomatic HIV infection. Analysis of titers of anti-Hbs, antibodies against cytomegalovirus, herpes simplex virus type I, rubella virus and toxoplasma gondii]M Radkowski, T Laskus, E W Kopicz-Kamińska, et al.

The Journal of Infectious Diseases|February 1, 1997

Distribution of infecting hepatitis C virus genotypes in end-stage liver disease patients at a large American transplantation centerH E Vargas, L F Wang, T Laskus, et al.

Advances in Medical Sciences|September 13, 2012

Variability of hepatitis C virus hypervariable region 1 (HVR-1) during the early phase of pegylated interferon and ribavirin therapyK Caraballo Cortés, T Laskus, I Bukowska-Ośko, et al.

Pageof 78

Showing results (71-80 of 776) with videos related to

Sort By:

Pageof 78

Polskie Archiwum Medycyny Wewnetrznej|January 1, 1992

[Occurrence of antibodies against hepatitis C virus (HCV) among drug addicts]T Laskus, M Radkowski, T Werezyńska, et al.

Polskie Archiwum Medycyny Wewnetrznej|February 1, 1992

[Markers of HBV infection in drug addicts]T Laskus, M Radkowski, T Werezyńska, et al.

Polskie Archiwum Medycyny Wewnetrznej|November 1, 1991

[Delta virus infection among drug addicts]T Laskus, M Radkowski, E Lupa, et al.

Journal of Hepatology|May 1, 1992

Prevalence of markers of hepatotropic viruses among drug addicts in Warsaw, PolandT Laskus, M Radkowski, E Lupa, et al.

Polskie Archiwum Medycyny Wewnetrznej|December 1, 1991

[Influence of therapy with glucocorticosteroids on clinical status, t4 lymphocyte count and t4/t8 lymphocyte ratio in people infected with AIDS]M Radkowski, T Laskus, E Kopicz-Kamińska, et al.

Polski Tygodnik Lekarski (Warsaw, Poland : 1960)|March 1, 1993

[Appearance of thrombocytopenia in patients infected with HIV]M Radkowski, T Laskus, B Szymańska, et al.

Journal of Hepatology|June 1, 1994

Naturally occurring hepatitis B virus mutants with deletions in the core promoter regionT Laskus, J Rakela, M J Tong, et al.

Polskie Archiwum Medycyny Wewnetrznej|August 1, 1993

[Evaluation of humoral immune response in patients with asymptomatic and symptomatic HIV infection. Analysis of titers of anti-Hbs, antibodies against cytomegalovirus, herpes simplex virus type I, rubella virus and toxoplasma gondii]M Radkowski, T Laskus, E W Kopicz-Kamińska, et al.

The Journal of Infectious Diseases|February 1, 1997

Distribution of infecting hepatitis C virus genotypes in end-stage liver disease patients at a large American transplantation centerH E Vargas, L F Wang, T Laskus, et al.

Advances in Medical Sciences|September 13, 2012

Variability of hepatitis C virus hypervariable region 1 (HVR-1) during the early phase of pegylated interferon and ribavirin therapyK Caraballo Cortés, T Laskus, I Bukowska-Ośko, et al.

Pageof 78